Table 1.
Interview participants who consented to ACROBAT trial study
| Participant | Site | Time between birth and interview | Age group (years) | Ethnicity |
| Participant 1 | Control site 1 | 5 months | 40+ | Black British |
| Participant 2 | Intervention site 1 | 4 months | 20–29 | White (Other European) |
| Participant 3 | Intervention site 2 | 3 months | 30–39 | White British |
| Participant 4 | Intervention site 2 | 7 months | 30–39 | Asian |
| Participant 5 | Intervention site 1 | 5 months | 20–29 | Asian British |
| Participant 6 | Control site 1 | 6 months | 30–39 | White (Other European) |
| Participant 7 | Intervention site 1 | 4 months | 30–39 | Black African |
| Participant 8 | Intervention site 2 | 4 months | 40+ | White British |
| Participant 9 | Control site 2 | 6 months | 30–39 | Black British |
| Participant 10 | Control site 2 | 6 months | 40+ | White (Other European) |
ACROBAT, Administering CRyoprecipitate in Obstetric Bleeding At an earlier Time.